TP
Tejashri Purohit-Sheth
Allergy & Immunology
Credentials: · ·
History
1994–1997Naval Medical Center
- 1990–1994
Research
Clinical Trials · 2014 · 26 citations
FDA Approval Summary: Lisocabtagene Maraleucel for Second-Line Treatment of Large B-Cell Lymphoma
Clinical Cancer Research · 2024 · 14 citations
FDA Approval Summary: Axicabtagene Ciloleucel for Second-Line Treatment of Large B-Cell Lymphoma
Clinical Cancer Research · 2023 · Last of 6 authors
- MT
4 papers
- YK
3 papers
- LL
2 papers
- NB
2 papers
- AJ
1 paper
- DP
1 paper
- HP
1 paper · 1 as a resident
- JM
1 paper